NIH

Using revolutionary CRISPR technology, Vanderbilt investigators have developed a fast and simple method to simultaneously turn off multiple genes in order to study complex diseases. Read More

Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States. Read More

Nanibaa' Garrison, Ph.D., assistant professor of Pediatrics and Anthropology, has been appointed to serve on the Working Group on Diversity, which is an arm of the Advisory Committee to the Director (ACD) of the National Institutes of Health (NIH). Read More

Last week in Langford Auditorium, Francis Collins, M.D., Ph.D., director of the National Institutes of Health (NIH), delivered what he referred to as a “romp through an awful lot of the landscape of biomedical research.” Read More

Affirmation of Vanderbilt University Medical Center’s high profile in precision medicine came last week when a new working group convened by the National Institutes of Health (NIH) visited Vanderbilt for a two-day public workshop devoted to planning a key component of the federal Precision Medicine Initiative announced earlier this year by President Obama. Read More

Unstable federal research funding and reductions in health care revenue for academic medical centers threatens to undermine the nation’s biomedical research enterprise, and in turn clinical medicine, which the nation needs now more than ever. Read More

National Institutes of Health Director Francis Collins, M.D., Ph.D., will deliver a special Discovery Lecture at Vanderbilt University Medical Center next Thursday, May 28. Read More

The enzyme alkaline phosphatase may provide a new therapeutic option for women at high risk of pregnancy complications due to bacterial toxin exposure. Read More

Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies. Read More

A metabolic change in adult stem cells makes them less “fit” for regenerative heart therapies, suggesting that strategies to prevent this response may boost the therapeutic usefulness of the cells. Read More

On May 28-29 at Vanderbilt, the Precision Medicine Initiative Working Group of the Advisory Committee to the Director of the National Institutes of Health (NIH) will hold a public workshop devoted to research cohorts and electronic health records. Read More

A novel mechanism could point to new therapies for a group of inherited diseases that share pathological features. Read More

Vanderbilt biologists have localized the seasonal light cycle effects that drive seasonal affective disorder to a small region of the brain called the dorsal raphe nucleus. Read More

The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered. Read More

Vanderbilt researchers have discovered a novel mechanism for the development of dendritic spines – sites of nerve cell communication. Read More

Vanderbilt researchers have discovered that profound defects exist in the integrity of structural RNA molecules in patients with relapsing remitting multiple sclerosis. Read More

Changes in the kidney can limit the blood pressure-lowering effects of thiazide diuretics, a new study reports. Read More

Vanderbilt researchers have identified the role that a key protein associated with autism and the co-occurrence of alcohol dependency and depression plays in forming the spines that create new connections in the brain. Read More

New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas. Read More

Peabody professors contributed to new book that explores the behavioral, neurobiological, and genetic components of reading comprehension. Read More